Pharmacology and Antitumor Activity of ABC294640, a Selective Inhibitor of Sphingosine Kinase-2Kevin J. French, Charles D. Smith|Journal of Pharmacology and Experimental Therapeutics|2010Cited by 313
A Novel Sphingosine Kinase Inhibitor Induces Autophagy in Tumor CellsVladimir Beljanski, Charles D. Smith|Journal of Pharmacology and Experimental Therapeutics|2010Cited by 111
Characterization of Isoenzyme-Selective Inhibitors of Human Sphingosine KinasesPeng Gao, Charles D. Smith|PLoS ONE|2012Cited by 107
Recent Progress in the Development of Opaganib for the Treatment of Covid-19Charles D. Smith, Mark L. Levitt|Drug Design Development and Therapy|2022Cited by 27
Opaganib (ABC294640) Induces Immunogenic Tumor Cell Death and Enhances Checkpoint Antibody TherapyLynn W. Maines, Charles D. Smith|International Journal of Molecular Sciences|2023Cited by 18